- Home
- PSIG vs PMCB Comparison
PSIG vs PMCB Comparison
Compare PSIG & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIG
- PMCB
- Stock Information
- Founded
- PSIG 1993
- PMCB 1996
- Country
- PSIG Hong Kong
- PMCB United States
- Employees
- PSIG N/A
- PMCB N/A
- Industry
- PSIG
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSIG
- PMCB Health Care
- Exchange
- PSIG NYSE
- PMCB Nasdaq
- Market Cap
- PSIG 11.9M
- PMCB 11.4M
- IPO Year
- PSIG N/A
- PMCB N/A
- Fundamental
- Price
- PSIG $0.51
- PMCB $1.76
- Analyst Decision
- PSIG
- PMCB
- Analyst Count
- PSIG 0
- PMCB 0
- Target Price
- PSIG N/A
- PMCB N/A
- AVG Volume (30 Days)
- PSIG 239.3K
- PMCB 27.2K
- Earning Date
- PSIG 12-12-2024
- PMCB 03-17-2025
- Dividend Yield
- PSIG N/A
- PMCB N/A
- EPS Growth
- PSIG N/A
- PMCB N/A
- EPS
- PSIG N/A
- PMCB 0.74
- Revenue
- PSIG $112,317,226.00
- PMCB N/A
- Revenue This Year
- PSIG N/A
- PMCB N/A
- Revenue Next Year
- PSIG N/A
- PMCB N/A
- P/E Ratio
- PSIG N/A
- PMCB $2.37
- Revenue Growth
- PSIG N/A
- PMCB N/A
- 52 Week Low
- PSIG $0.38
- PMCB $1.39
- 52 Week High
- PSIG $4.20
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- PSIG N/A
- PMCB 60.08
- Support Level
- PSIG N/A
- PMCB $1.57
- Resistance Level
- PSIG N/A
- PMCB $1.66
- Average True Range (ATR)
- PSIG 0.00
- PMCB 0.12
- MACD
- PSIG 0.00
- PMCB 0.02
- Stochastic Oscillator
- PSIG 0.00
- PMCB 68.89
About PSIG PS INTERNATIONAL GROUP LTD
PS International Group Ltd is a freight forwarding service provider in Hong Kong with networks across the globe. It provides air and ocean export and import freight forwarding services with optional ancillary logistics-related services such as cargo pick up, cargo handling at ports, and local transportation and warehousing-related services such as repackaging, labeling, palletization, preparation of shipping documentation, arrangement of customs clearance and warehousing to meet the requirement of customers.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.